CUV 0.00% $14.30 clinuvel pharmaceuticals limited

Everyone knew exactly what results would be coming out from this...

  1. 3,567 Posts.
    Everyone knew exactly what results would be coming out from this stock and hence the lack of surprise. Again a lot of punters are selling into the news but in 1-2 years the stock should double again.

    Patience will be rewarded here. The big risk are longer term side affects in these clinical trial patients.

    Cheers,
    Munch.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.